Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553577 · ClinicalTrials.gov registry record
Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes
A clinical trial, sponsored by Kristin Ashford.
- Completed
- Registry status
- 278
- Enrollment target
NCT02553577: Completed study, sponsored by Kristin Ashford.
NCT02553577 is a clinical trial that has completed, run by Kristin Ashford. The registered enrollment target is 278 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02553577 has completed, sponsored by Kristin Ashford.
- COMPLETED
- Registry status
- 278 participants
- Enrollment target
Study Summary
There has been a dramatic escalation of electronic cigarette (e-cig) use among women of childbearing age, including pregnant women. The overall goal of this study is to determine the effects of e-cigs on prenatal biomarkers and birth outcomes. It is imperative that more data about these effects be available to better inform women of childbearing age.
Primary Outcome
Investigators will determine if there is a significant difference in gestational age at birth among three groups: pregnant women who use conventional tobacco-only; pregnant women who use e-cig only; and dual users
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2016-01-13 |
| Est. Completion | 2021-02-28 |
What the finished NCT02553577 record still lists
NCT02553577 is an observational study that tracks outcomes without assigning an intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02553577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02553577 about?
NCT02553577 is a clinical study titled "Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes". There has been a dramatic escalation of electronic cigarette (e-cig) use among women of childbearing age, including pregnant women. The overall goal of this study is to determine the effects of e-cigs on prenatal biomarkers and birth outcomes. It is imperative that more data about these effects be a...
What is the current status of trial NCT02553577?
This trial is currently completed. The enrollment target is 278 participants. The study started on 2016-01-13. Estimated completion is 2021-02-28.
Who is sponsoring clinical trial NCT02553577?
This trial is sponsored by Kristin Ashford, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI